Treatment of Refractory Colorectal Cancer: Regorafenib vs. TAS-102
Crossref DOI link: https://doi.org/10.1007/s11888-017-0381-6
Published Online: 2017-06-14
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jeong, Jae Ho
Hong, Yong Sang
Kim, Tae Won
License valid from 2017-06-14